News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
725,375 Results
Type
Article (43762)
Company Profile (295)
Press Release (681318)
Multimedia
Podcasts (85)
Webinars (12)
Section
Business (212369)
Career Advice (2198)
Deals (36924)
Drug Delivery (110)
Drug Development (83483)
Employer Resources (177)
FDA (16650)
Job Trends (15486)
News (358962)
Policy (34282)
Tag
Academia (2631)
Accelerated approval (5)
Adcomms (21)
Allergies (90)
Alliances (51685)
ALS (96)
Alzheimer's disease (1411)
Antibody-drug conjugate (ADC) (139)
Approvals (16645)
Artificial intelligence (275)
Autoimmune disease (26)
Automation (16)
Bankruptcy (375)
Best Places to Work (11813)
BIOSECURE Act (20)
Biosimilars (113)
Biotechnology (189)
Bladder cancer (79)
Brain cancer (29)
Breast cancer (289)
Cancer (2337)
Cardiovascular disease (188)
Career advice (1846)
Career pathing (31)
CAR-T (154)
Cell therapy (440)
Cervical cancer (20)
Clinical research (67895)
Collaboration (875)
Company closure (1)
Compensation (558)
Complete response letters (25)
COVID-19 (2688)
CRISPR (47)
C-suite (261)
Cystic fibrosis (105)
Data (2289)
Decentralized trials (2)
Denatured (29)
Depression (48)
Diabetes (279)
Diagnostics (6493)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (125)
Drug pricing (115)
Drug shortages (29)
Duchenne muscular dystrophy (99)
Earnings (89467)
Editorial (43)
Employer branding (21)
Employer resources (151)
Events (116323)
Executive appointments (759)
FDA (17989)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (778)
Gene editing (116)
Generative AI (21)
Gene therapy (329)
GLP-1 (764)
Government (4631)
Grass and pollen (5)
Guidances (108)
Healthcare (19169)
Huntington's disease (25)
IgA nephropathy (28)
Immunology and inflammation (130)
Indications (30)
Infectious disease (2834)
Inflammatory bowel disease (148)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (99)
Interviews (344)
IPO (16897)
IRA (47)
Job creations (4089)
Job search strategy (1569)
Kidney cancer (10)
Labor market (40)
Layoffs (498)
Leadership (19)
Legal (8484)
Liver cancer (77)
Lung cancer (324)
Lymphoma (157)
Machine learning (8)
Management (59)
Manufacturing (341)
MASH (74)
Medical device (13553)
Medtech (13558)
Mergers & acquisitions (20584)
Metabolic disorders (729)
Multiple sclerosis (83)
NASH (17)
Neurodegenerative disease (98)
Neuropsychiatric disorders (29)
Neuroscience (1982)
NextGen: Class of 2025 (6684)
Non-profit (4565)
Now hiring (40)
Obesity (390)
Opinion (234)
Ovarian cancer (78)
Pain (102)
Pancreatic cancer (89)
Parkinson's disease (153)
Partnered (21)
Patents (246)
Patient recruitment (116)
Peanut (49)
People (59925)
Pharmaceutical (91)
Pharmacy benefit managers (21)
Phase I (21065)
Phase II (29854)
Phase III (22385)
Pipeline (1295)
Policy (158)
Postmarket research (2694)
Preclinical (8980)
Press Release (68)
Prostate cancer (109)
Psychedelics (34)
Radiopharmaceuticals (256)
Rare diseases (400)
Real estate (6300)
Recruiting (68)
Regulatory (23355)
Reports (46)
Research institute (2395)
Resumes & cover letters (368)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (79)
Series A (134)
Series B (89)
Service/supplier (12)
Sickle cell disease (55)
Special edition (16)
Spinal muscular atrophy (150)
Sponsored (30)
Startups (3756)
State (2)
Stomach cancer (14)
Supply chain (70)
Tariffs (49)
The Weekly (54)
Vaccines (724)
Venture capitalists (41)
Weight loss (258)
Women's health (36)
Worklife (16)
Date
Today (295)
Last 7 days (876)
Last 30 days (2957)
Last 365 days (33316)
2025 (11536)
2024 (35959)
2023 (40832)
2022 (52030)
2021 (56533)
2020 (55060)
2019 (47718)
2018 (36035)
2017 (33417)
2016 (33004)
2015 (38942)
2014 (32876)
2013 (27985)
2012 (30102)
2011 (30818)
2010 (28857)
Location
Africa (801)
Alabama (53)
Alaska (7)
Arizona (242)
Arkansas (14)
Asia (41310)
Australia (6648)
California (6318)
Canada (2055)
China (549)
Colorado (276)
Connecticut (281)
Delaware (157)
Europe (88530)
Florida (933)
Georgia (210)
Idaho (57)
Illinois (563)
India (26)
Indiana (323)
Iowa (11)
Japan (172)
Kansas (104)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (918)
Massachusetts (4762)
Michigan (224)
Minnesota (399)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (65)
New Hampshire (64)
New Jersey (1789)
New Mexico (29)
New York (1793)
North Carolina (1013)
North Dakota (8)
Northern California (2764)
Ohio (211)
Oklahoma (14)
Oregon (39)
Pennsylvania (1414)
Puerto Rico (12)
Rhode Island (33)
South America (1185)
South Carolina (25)
South Dakota (1)
Southern California (2374)
Tennessee (103)
Texas (943)
United States (23909)
Utah (189)
Virginia (159)
Washington D.C. (66)
Washington State (565)
West Virginia (3)
Wisconsin (59)
725,375 Results for "fresenius kabi pharmaceuticals holding inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CMS Grants Fresenius Kabi Permanent, Product-Specific Q-Code for Otulfi® (ustekinumab-aauz)
April 29, 2025
·
11 min read
Press Releases
BioLife Plasma Services Introduces the New Fresenius Kabi Adaptive Nomogram Across its U.S. Network of Plasma Donation Centers
May 5, 2025
·
7 min read
Press Releases
Fresenius Kabi Introduces Calcitonin Salmon Injection, USP Synthetic
February 10, 2025
·
5 min read
Press Releases
Fresenius Kabi Canada has received a Health Canada Notice of Compliance (NOC) for Otulfi™* an Ustekinumab Biosimilar
January 9, 2025
·
7 min read
FDA
Fresenius Kabi’s Biosimilar for Actemra Gets FDA Approval
According to Fresenius Kabi, Tyenne is the first biosimilar to Genentech’s Acterma which has both IV and subcutaneous formulations approved by the FDA.
March 8, 2024
·
2 min read
·
Tyler Patchen
Press Releases
Fresenius Kabi Launches Epinephrine Injection, USP Expanding U.S. Pharma Portfolio
December 17, 2024
·
6 min read
Press Releases
Fresenius Kabi Receives FDA 510(k) Clearance for Adaptive Nomogram, Enhancing Plasma Collection Efficiency with the Aurora Xi Plasmapheresis System
January 28, 2025
·
6 min read
Press Releases
Fresenius Kabi Receives 2024 Novaplus Program Excellence Award from Vizient
November 14, 2024
·
3 min read
BioMidwest
Angels for Change 2024 Drug Shortage Guardian Award Presented to Fresenius Kabi USA
Angels for Change, a global non-profit on a mission to end drug shortages, presented the organization’s 2024 Drug Shortage Guardian Award to Fresenius Kabi USA, a health care company that specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition.
June 6, 2024
·
4 min read
BioMidwest
Fresenius Kabi Launches Posaconazole Injection for Prevention or Treatment of Fungal Infections
Fresenius Kabi Launches Posaconazole Injection for Prevention or Treatment of Fungal Infections.
January 29, 2024
·
6 min read
1 of 72,538
Next
